 |
 China’s dynamic health care sector is creating numerous opportunities for
pharmaceutical companies, health care providers, and health insurance companies.
Income growth and an aging population are driving demand for health care
products and services. The government’s recent broad-based health care reforms
will give even more people access to insurance coverage and health care
services, further driving spending on health care in China.
McKinsey’s Greater China Health Care & Pharmaceuticals Practice works closely with health care suppliers, hospitals, and insurance companies to transform their operations. We also help clients design corporate and product portfolio strategies, prepare and implement M&A strategies, and optimize sales and marketing approaches. We advise pharmaceutical clients on licensing and alliance opportunities, portfolio management, and R&D strategy. Our work also covers sales force management, direct-to-consumer advertising, global product launches, and patent life-cycle management. We also advise hospitals on the design and implementation of strategies to enhance productivity while improving the quality of care.
 | | | Operational Transformation in a Pharmaceutical Company | | | A state-owned pharmaceutical manufacturer was failing to meet the performance levels of its competitors and needed to stimulate its sluggish growth.
| |
|
|
|
|
|
|
 |
